politics
Supreme Court deals blow to Big Pharma
Key takeaways
- Link copied by Joseph Choi and Nathaniel Weixel - 05/18/26 6:25 PM ET Link copied Close Thank you for signing up!
- The Supreme Court declined to take up petitions from several of the country s largest pharmaceutical companies challenging the Medicare drug price negotiation program.
- The drugmakers appeals were considered longshots, as the lower courts were almost all in agreement.
Why this matters: political developments that affect policy direction and public trust.
Link copied by Joseph Choi and Nathaniel Weixel - 05/18/26 6:25 PM ET Link copied Close Thank you for signing up!
The Supreme Court declined to take up petitions from several of the country s largest pharmaceutical companies challenging the Medicare drug price negotiation program.
The decision leaves several lower court rulings upholding the program that Congress enacted as part of the Biden administration s Inflation Reduction Act 2022. The justices did not issue comments with the decision.
Article preview — originally published by The Hill. Full story at the source.
Read full story on The Hill →
More top stories
Also covered by
The Hindu
Supreme Court upholds bail for man booked under UAPA
Times of India
Supreme Court: Courts not bound by govt’s N-liability cap
Investing.com
US Supreme Court’s uneven approach to election-map rulings boosts Republicans
The Hindu
Protest is a right as long as it does not break the peace: Supreme Court
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop